Ma. Olman et al., CHANGES IN PROCOAGULANT AND FIBRINOLYTIC GENE-EXPRESSION DURING BLEOMYCIN-INDUCED LUNG INJURY IN THE MOUSE, The Journal of clinical investigation, 96(3), 1995, pp. 1621-1630
Bleomycin-induced lung injury is an established murine model of human
pulmonary fibrosis, Although procoagulant molecules (e.g., tissue fact
or [TF]) and fibrinolytic components (e.g., urokinase [u-PA] and type
1 plasminogen activator inhibitor [PAI-1]) have been detected in alveo
lar fluid from injured lungs, the origin of these molecules remains un
known, We therefore examined the expression of procoagulant and fibrin
olytic components in relation to the distribution of parenchymal fibri
n in bleomycin-injured lungs, Extravascular fibrin localized to the al
veolar and extracellular matrix in injured lung tissue, Injured lung t
issue extracts contained elevated levels of PAI-1 activity and decreas
ed levels of u-PA activity, Whole lung PAI-1 and TP mRNAs were dramati
cally induced by lung injury, In situ hybridization of injured lungs r
evealed that PAI-1, u-PA, and TF mRNAs were induced within the fibrin-
rich fibroproliferative lesions, primarily in fibroblast-like and macr
ophagelike cells, respectively, while TF mRNA was also induced in peri
lesional alveolar cells, Taken together, these observations suggest th
at the induction of PAI-1 and TF gene expression plays an important ro
le in the formation and persistence of extracellular fibrin in bleomyc
in injured murine lungs.